Close navigation

What we're funding

We are the leading funder of brain tumour research in the UK, committing over £50 million to date on pioneering projects that will help adults and children with brain tumours.

We fund research through a competitive, fair and transparent process of best practice called peer review to ensure we only select the very best research that will have a real impact on those affected by brain tumours.

Our new research grants

We're pleased to announce our most recent research awards. Our Scientific Advisory Board told us that these are the highest quality grants with the best chance of success. We look forward to seeing their progress in the coming months and years.

Dr Jan Schuemann

Extreme dose rate proton therapy

share this

Dr Jan Schuemann

Extreme dose rate proton therapy

Previous studies have shown that delivering radiotherapy extremely rapidly can dramatically reduce side-effects. Radiation therapy that delivers the same dose of radiation in a much shorter period of time is called extreme dose radiation (EDR). EDR therapy has not been tested using proton beams, and that’s where this innovative research project comes in.

The research team, led by Dr Schuemann, will use pre-clinical models to test EDR proton therapy with the aim of establishing a treatment regimen that’s effective and well-tolerated by people. They’ll compare EDR to conventional radiation delivery and look for any differences in side-effects, specifically looking into the effects on cognition and motor control.

Learn more

share this

Professor Simona Parrinello

Mapping glioblastoma cells

share this

Professor Simona Parrinello

Mapping glioblastoma cells

Professor Parrinello, and her colleagues at Imperial College London, aim to understand how glioblastomas spread into the brain and how they use small molecules as messengers to communicate with surrounding cells.

Find out more

share this

Professor Richard Gilbertson

No brain tumour ignored

share this

Professor Richard Gilbertson

No brain tumour ignored

This grant is for a large programme of work into two different rare childhood brain tumours. Professor Gilbertson will focus on three main areas of work: making better models to use in the lab, discovering and testing new drugs, and trialling the best way to deliver new drugs to tumours.

Find out more

share this

Dr Sophie Thomas

Rebuilding a meaningful life for young people

share this

Dr Sophie Thomas

Rebuilding a meaningful life for young people

Acceptance and Commitment Therapy (ACT) is a psychological intervention with a broad focus. Dr Sophie Thomas aims to assess the feasibility and acceptability of ACT to help young people, aged 11-24 years, who have survived a childhood brain tumour.

Find out more

share this

Professor Michael Hawkins

Improving Survival for Survivors

share this

Professor Michael Hawkins

Improving Survival for Survivors

This research project, led by Professor Hawkins, aims to establish one system that would allow us to monitor the health outcomes of brain tumour survivors under the age of 40. This system would help us track the risks associated with surviving a brain tumour and then help us to identify groups of survivors that have increased risk of poor health outcomes.

Find out more

share this

Professor Roel Verhaak

Tracking and Targeting Glioblastoma

share this

Professor Roel Verhaak

Tracking and Targeting Glioblastoma

Professor Verhaak aims to understand how extra chromosomal DNA or ecDNA is created and maintained in cancer cells, and will then go on to develop strategies to treat glioblastomas by targeting ecDNA.

Find out more

share this

Targeting, treating and defeating glioblastoma

share this

Professor Neil Carragher

Targeting, treating and defeating glioblastoma

Professor Carragher will adopt a systematic approach to find new drug targets and new drug combinations to treat glioblastomas. In addition to discovering new combinations of drugs, they’ll continue their work by testing drug combinations already discovered by their team.

This grant will allow researchers to suggest new combinations of therapies which have the greatest chance of being effective and well-tolerated in people. We hope that these new therapy combinations will signify a real step-change in the lives of people with a glioblastoma, improving quality of life and length of survival.

Learn more

share this

Research projects

As part of our research strategy, A Cure Can't Wait, we have established various funding opportunities to achieve our goals of doubling survival and halving the harm caused by a brain tumour. More information about the different types of grants we fund can be found below:

Child brain tumour research

Current and past research projects to enhance our understanding of tumours and how to treat them

Learn more

Adult brain tumour research

Read about our current and past research projects, furthering our understanding of adult brain tumours and treatments

Learn more